Caxton Associates (New York)’s IDEX IEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,218
Closed -$1.34M 506
2023
Q2
$1.34M Hold
6,218
0.2% 115
2023
Q1
$1.44M Buy
6,218
+3,946
+174% +$896K 0.22% 89
2022
Q4
$519K Buy
+2,272
New +$508K 0.03% 228
2021
Q2
Sell
-1,741
Closed -$364K 531
2021
Q1
$364K Buy
+1,741
New +$345K 0.03% 225
2017
Q4
Sell
-28,750
Closed -$3.49M 428
2017
Q3
$3.49M Buy
28,750
+9,800
+52% +$1.14M 0.12% 156
2017
Q2
$2.14M Buy
+18,950
New +$1.99M 0.08% 186
2014
Q3
Sell
-6,500
Closed -$525K 229
2014
Q2
$525K Buy
+6,500
New +$492K 0.03% 146
2013
Q4
Sell
-24,000
Closed -$1.57M 256
2013
Q3
$1.57M Buy
+24,000
New +$1.45M 0.08% 103

Other funds holding IEX

Caxton Associates (New York)'s IEX Position: Q3 2023 in Review

Caxton Associates (New York) sold out of IDEX (IEX) in Q3 2023, closing a stake of 6,218 shares — an estimated $1.34M sold.

Caxton Associates (New York) first reported a position in IEX in Q3 2013 and held it in 8 quarters. The position peaked at $3.49M in Q3 2017. 617 funds tracked by Wall St. Rank hold IEX as of Q3 2023.

  • Caxton Associates (New York) reported no remaining IDEX position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 6,218 IDEX shares in Q3 2023, an estimated $1.34M.
  • Caxton Associates (New York) first reported a position in IDEX in Q3 2013 and held it in 8 quarters.
  • Caxton Associates (New York)'s IDEX position peaked at $3.49M in Q3 2017.
  • 617 funds tracked by Wall St. Rank held IDEX as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.